Pharmaceuticals in France

Date: September 26, 2016
Pages: 33
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PFACDE709F7EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in France
SUMMARY

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the France pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the France pharmaceuticals market by value in 2015?
  • What will be the size of the France pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the France pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in France's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The French pharmaceuticals market had total revenues of $31.0bn in 2015, representing a compound annual rate of change (CARC) of -0.8% between 2011 and 2015.

France was later to adopt generics than Germany or the UK and much of this restricted growth is due to the switching over to generics of some markets, generics accounting for around 30% of the drugs market.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.6% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $35.1bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Laboratoires Pierre Fabre SA
Les Laboratoires Servier
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: France pharmaceuticals market value: $ billion, 2011-15
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: France pharmaceuticals market share: % share, by value, 2015
Table 4: France pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Laboratoires Pierre Fabre SA: key facts
Table 9: Les Laboratoires Servier: key facts
Table 10: Sanofi SA: key facts
Table 11: Sanofi SA: key financials ($)
Table 12: Sanofi SA: key financials (€)
Table 13: Sanofi SA: key financial ratios
Table 14: France size of population (million), 2011-15
Table 15: France gdp (constant 2005 prices, $ billion), 2011-15
Table 16: France gdp (current prices, $ billion), 2011-15
Table 17: France inflation, 2011-15
Table 18: France consumer price index (absolute), 2011-15
Table 19: France exchange rate, 2011-15

LIST OF FIGURES

Figure 1: France pharmaceuticals market value: $ billion, 2011-15
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: France pharmaceuticals market share: % share, by value, 2015
Figure 4: France pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in France, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2015
Figure 11: AstraZeneca PLC: revenues and profitability
Figure 12: AstraZeneca PLC: assets and liabilities
Figure 13: Sanofi SA: revenues and profitability
Figure 14: Sanofi SA: assets and liabilities

COMPANIES MENTIONED

AstraZeneca PLC
Laboratoires Pierre Fabre SA
Les Laboratoires Servier
Sanofi SA
Skip to top


OTC Pharmaceuticals in France US$ 350.00 Sep, 2016 · 37 pages
Pharmaceuticals Global Industry Guide_2016 US$ 1,495.00 Oct, 2016 · 285 pages

Ask Your Question

Pharmaceuticals in France
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: